Compare Nano Dimension Ltd - ADR (NNDM) vs Tenet Healthcare Corporation (THC) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Nano Dimension Ltd - ADR vs Tenet Healthcare Corporation — how do they compare? Nano Dimension Ltd - ADR trades at $1.67 (market cap $350.49M), while Tenet Healthcare Corporation trades at $264 (market cap $20.89B). The key difference: Tenet Healthcare Corporation is far larger — about 59.6× Nano Dimension Ltd - ADR's market cap, and Tenet Healthcare Corporation is trading nearer its 52-week high, Nano Dimension Ltd - ADR nearer its low. Which is the better fit depends on your goals.
| NNDM | THC | |
|---|---|---|
Market Cap | $350.49M | $20.89B |
Sector | Technology | Health |
52-Week High | $2.14 | $262.63 |
52-Week Low | $1.21 | $161.37 |
Enterprise Value | -$54.35M | $31.97B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Nano Dimension (NNDM) trades at $1.63, showing no change recently. The stock exhibits a bullish technical signal with strong moving average support, though RSI levels suggest overbought conditions. Fundamentally, the company reported revenue growth to $102.44M in 2025 but posted a significant net loss of $293.30M, reflecting ongoing profitability challenges. Recent strategic actions include cost-saving initiatives and the planned sale of MarkForged to Stratasys, aimed at reducing cash burn.
The outlook remains speculative due to persistent losses and cash flow concerns, despite potential from strategic divestitures. Investment opportunities hinge on successful execution of cost reductions and future profitability. Key risks include high cash burn, competitive pressures, and execution uncertainty amid leadership changes.
Tenet Healthcare (THC) trades at $260.67, up 0.28% today, with strong technical momentum including a golden cross pattern and bullish moving average alignment. The company demonstrates robust fundamentals with Q2 2026 EPS beating expectations at $6.12 versus $4.26 forecast, maintaining a three-quarter earnings beat streak. Valuation metrics remain attractive with P/E of 10.03 and EV/EBITDA of 5.73, while profitability metrics show exceptional ROE of 53.31% and net margin of 9.9%.
The investment outlook remains positive with 81% analyst buy ratings and $281.44 consensus price target representing 8% upside. Key risks include policy headwinds in ACA exchanges and hospital segment challenges, though strong ambulatory growth provides offset. The stock presents a compelling value-growth combination with momentum characteristics, supported by institutional accumulation and positive earnings revisions.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Nano Dimension Ltd - ADR
Nano Dimension Ltd is engaged in research and development of a three-dimensional printer that prints electronic circuit boards, also known as printed circuit boards, and ink materials and products based on nanotechnology. Its products consist of two main product lines - Dragonfly 2020 3D printer and proprietary ink products. The company's Dragonfly 2020 3D printer currently in development uses proprietary ink and integrated software to quickly create fully functioning PCB prototypes. Geographically, it generates maximum revenue from the USA followed by the Asia Pacific and Europe and Israel. It serves the Commercial, Research and Printing services industries.
Read more on NNDM →About Tenet Healthcare Corporation
Tenet Healthcare is a leading diversified healthcare services company that has strategically pivoted toward high-growth ambulatory care. Operating through United Surgical Partners International (USPI), the largest ambulatory platform in the U.S., Tenet manages an expansive network of surgical centers, acute care hospitals, and specialty facilities. The company’s focus on high-acuity services and operational efficiency, supported by its revenue cycle management subsidiary Conifer Health Solutions, positions it as a resilient leader in the evolving U.S. healthcare landscape.
Read more on THC →
